Stories Archives - Insights

Living with ultra-rare epilepsy and chasing her dream: Giana Urse

Robin Huiras-Carlson — Mon, 20 Jul 2026 12:00:00 +0000

Supported by Mayo Clinic’s holistic, precision medicine approach, which included advanced genetic insights, access to an emerging therapy, and tailored treatment monitoring, Giana Urse gained the confidence and clarity she needed to pursue her dream of becoming a dog trainer.

The post Living with ultra-rare epilepsy and chasing her dream: Giana Urse appeared first on Insights.

Phenotype-specific approach transcends traditional testing for autoimmune neurological conditions

Chris Bahnsen — Mon, 08 Jun 2026 13:00:00 +0000

Autoimmune neurology testing has evolved beyond limited paraneoplastic evaluations to phenotype-specific panels that identify clinically relevant antibodies. This phenotype-specific approach significantly improves diagnostic accuracy, reduces false positives, and helps guide faster, more personalized treatment for complex neurological diseases.

The post Phenotype-specific approach transcends traditional testing for autoimmune neurological conditions appeared first on Insights.

New assay can detect fusions in 1,445 genes across wide range of tumors

Chris Bahnsen — Mon, 20 Apr 2026 13:00:00 +0000

New wtRNA-seq test detects fusions in 1,445 genes with high accuracy, improving cancer diagnosis, treatment decisions, and clinical trial eligibility.

The post New assay can detect fusions in 1,445 genes across wide range of tumors appeared first on Insights.

A family’s journey with an ultra-rare disease: Isabel the incredible

Luci Gens — Mon, 06 Apr 2026 13:00:00 +0000

A young dancer from Minnesota thrives with a rare blood disorder, thanks to resilience, family advocacy, and lifesaving lab medicine.

The post A family’s journey with an ultra-rare disease: Isabel the incredible appeared first on Insights.

From Intake to Interpretation: How AI Assists Lab Teams Today

jgilligan1 — Mon, 23 Mar 2026 13:00:00 +0000

Mayo Clinic Laboratories is applying AI where it helps most today, strengthening daily workflows while keeping experts firmly in control. From faster specimen intake and triage to data‑informed scheduling, first‑pass support for complex analyses, draft interpretive reporting, and reliable digital pathology quantification, teams use AI to organize information, reduce repetitive steps, and improve consistency. Human‑in‑the‑loop oversight, fit‑for‑workflow design, and regulatory‑aware communication keep the focus on safe, practical gains that benefit patients, clinicians, and laboratorians.

The post From Intake to Interpretation: How AI Assists Lab Teams Today appeared first on Insights.

Cultivating a comprehensive test menu for organ transplant patients

Chris Bahnsen — Fri, 30 Jan 2026 14:00:00 +0000

Viral and pharmacogenomic testing help clinicians detect infection early, tailor immunosuppression, and improve long-term outcomes for organ transplant recipients.

The post Cultivating a comprehensive test menu for organ transplant patients appeared first on Insights.

Unraveling IgG4-related disease with coordinated diagnostic expertise

Chris Bahnsen — Mon, 17 Nov 2025 14:00:00 +0000

After months of misdiagnoses, Tom Heisler found answers at Mayo Clinic, where advanced renal pathology revealed IgG4-related disease and led to his recovery.

The post Unraveling IgG4-related disease with coordinated diagnostic expertise appeared first on Insights.

Transforming laboratory medicine through AI: From promise to practice

jgilligan1 — Mon, 06 Oct 2025 13:00:00 +0000

Artificial intelligence (AI) is reshaping laboratory medicine, not as a distant promise, but as a practical tool improving diagnostics, workflows, and quality. Through collaborative development, rigorous validation, and a commitment to ethical innovation, Mayo Clinic Laboratories is implementing AI-driven solutions that enhance precision, reduce turnaround times, and empower laboratorians to focus on what matters most: patient care.

The post Transforming laboratory medicine through AI: From promise to practice appeared first on Insights.

A simpler path to answers for patients with mast cell activation syndrome

Chris Bahnsen — Mon, 11 Aug 2025 13:00:00 +0000

A random urine test panel aids in diagnosing mast cell activation syndrome (MCAS), a complex condition often misdiagnosed due to overlapping symptoms. The panel improves access, speeds up diagnosis, and enables individualized treatment by detecting key mast cell mediators.

The post A simpler path to answers for patients with mast cell activation syndrome appeared first on Insights.

A Mayo Pathologist’s Journey through Paraneoplastic Syndrome and a Double Lung Transplant: Dr. Brad Karon

Chris Bahnsen — Mon, 21 Jul 2025 13:00:00 +0000

After mysterious neurological symptoms began in 2010, Brad Karon, M.D., Ph.D., was diagnosed with paraneoplastic syndrome, a rare condition that led to groundbreaking research and test development at Mayo Clinic. Years later, pulmonary fibrosis and a double lung transplant would test him once again — and redefine his resilience.

The post A Mayo Pathologist’s Journey through Paraneoplastic Syndrome and a Double Lung Transplant: Dr. Brad Karon appeared first on Insights.